Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Skinmed ; 20(5): 350-352, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36314698

RESUMEN

Melasma is a chronic cutaneous condition that not only affects the appearance of patients but also has an immense psychosocial impact on patient quality of life. Although many treatment options are currently available, there is no single universal treatment regimen that works for all patients. Significant attention has been recently focused on the development and use of topical treatments that can lighten the dark patches associated with melasma. One such ingredient that has received growing attention in recent years is cysteamine. It works through several mechanisms to influence the melanogenesis pathway. This commentary reviews the information on this topical ingredient and offers relevant clinical insights.


Asunto(s)
Cisteamina , Melanosis , Humanos , Cisteamina/uso terapéutico , Calidad de Vida , Melanosis/tratamiento farmacológico , Administración Tópica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA